Rapid Micro Biosystems
RPID
49 hedge funds and large institutions have $401M invested in Rapid Micro Biosystems in 2021 Q3 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
63.64% more ownership
Funds ownership: 0% → 63.64% (+64%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$174M |
| 2 |
DCP
D1 Capital Partners
New York
|
+$54.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.3M |
| 4 |
JP Morgan Chase
New York
|
+$34.8M |
| 5 |
BlackRock
New York
|
+$28.1M |
Top Sellers
RPID Hedge Fund Activity: Q3 2021 in Review
49 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q3 2021, worth a combined $401M.
Buyers outnumbered sellers: 49 funds opened new RPID positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $174M.
- 49 institutional investors held Rapid Micro Biosystems (RPID) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $401M of Rapid Micro Biosystems stock for Q3 2021.
- 49 funds opened new Rapid Micro Biosystems positions in Q3 2021 and 0 closed out, a net change of +49 holders.
- The largest Rapid Micro Biosystems buyer in Q3 2021 was Bain Capital Life Sciences Investors, an estimated $174M added.
Based on aggregated 13F filings for Q3 2021.